Search research articles
Contact Us
Filters
Showing results (661-670 of 708) with videos related to
Page
of 71
Sort By:
Journal of Cancer Research and Clinical Oncology
|
April 26, 2025
First-line pazopanib in patients with metastatic epithelioid hemangioendothelioma: a retrospective single-center analysis
Anton Burkhard-Meier, Vera Valerie Rechenauer, Vindi Jurinovic, et al.
Circulation
|
August 4, 2011
Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia
Ravi Thadhani, Tuelay Kisner, Henning Hagmann, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 15, 2025
Maintenance treatment with trofosfamide in patients with advanced soft tissue sarcoma - a retrospective single-centre analysis
Anton Burkhard-Meier, Vera Valerie Rechenauer, Luc M Berclaz, et al.
JAMA Oncology
|
May 30, 2020
Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors: An Analysis of a Randomized Clinical Trial After 10-Year Follow-up
Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, et al.
Nature Communications
|
June 14, 2019
Feedback inhibition of cAMP effector signaling by a chaperone-assisted ubiquitin system
Laura Rinaldi, Rossella Delle Donne, Bruno Catalanotti, et al.
JAMA Oncology
|
December 23, 2020
Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma: Final Results of the PAPAGEMO Phase 2 Randomized Clinical Trial
Hans-Joachim Schmoll, Lars H Lindner, Peter Reichardt, et al.
The Lancet. Respiratory Medicine
|
April 20, 2018
Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial
Patrick Schöffski, Jozef Sufliarsky, Hans Gelderblom, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
February 8, 2022
Hyperthermia-induced doxorubicin delivery from thermosensitive liposomes via MR-HIFU in a pig model
Lukas Christian Sebeke, Juan Daniel Castillo Gómez, Edwin Heijman, et al.
FEBS Letters
|
August 20, 2019
LAMTOR/Ragulator regulates lipid metabolism in macrophages and foam cell differentiation
Giorgia Lamberti, Cedric H De Smet, Mihaela Angelova, et al.
Nature Communications
|
May 29, 2024
Author Correction: Feedback inhibition of cAMP effector signaling by a chaperone-assisted ubiquitin system
Laura Rinaldi, Rossella Delle Donne, Bruno Catalanotti, et al.
Page
of 71
Search research articles
Search
Showing results (661-670 of 708) with videos related to
Sort By:
Page
of 71
Journal of Cancer Research and Clinical Oncology
|
April 26, 2025
First-line pazopanib in patients with metastatic epithelioid hemangioendothelioma: a retrospective single-center analysis
Anton Burkhard-Meier, Vera Valerie Rechenauer, Vindi Jurinovic, et al.
Circulation
|
August 4, 2011
Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia
Ravi Thadhani, Tuelay Kisner, Henning Hagmann, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 15, 2025
Maintenance treatment with trofosfamide in patients with advanced soft tissue sarcoma - a retrospective single-centre analysis
Anton Burkhard-Meier, Vera Valerie Rechenauer, Luc M Berclaz, et al.
JAMA Oncology
|
May 30, 2020
Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors: An Analysis of a Randomized Clinical Trial After 10-Year Follow-up
Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, et al.
Nature Communications
|
June 14, 2019
Feedback inhibition of cAMP effector signaling by a chaperone-assisted ubiquitin system
Laura Rinaldi, Rossella Delle Donne, Bruno Catalanotti, et al.
JAMA Oncology
|
December 23, 2020
Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma: Final Results of the PAPAGEMO Phase 2 Randomized Clinical Trial
Hans-Joachim Schmoll, Lars H Lindner, Peter Reichardt, et al.
The Lancet. Respiratory Medicine
|
April 20, 2018
Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial
Patrick Schöffski, Jozef Sufliarsky, Hans Gelderblom, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
February 8, 2022
Hyperthermia-induced doxorubicin delivery from thermosensitive liposomes via MR-HIFU in a pig model
Lukas Christian Sebeke, Juan Daniel Castillo Gómez, Edwin Heijman, et al.
FEBS Letters
|
August 20, 2019
LAMTOR/Ragulator regulates lipid metabolism in macrophages and foam cell differentiation
Giorgia Lamberti, Cedric H De Smet, Mihaela Angelova, et al.
Nature Communications
|
May 29, 2024
Author Correction: Feedback inhibition of cAMP effector signaling by a chaperone-assisted ubiquitin system
Laura Rinaldi, Rossella Delle Donne, Bruno Catalanotti, et al.
Page
of 71